SignatureFD’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

SignatureFD’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-150	Closed	-$8.89K	–	3246
2024 Q2	$8.89K	Hold	150	–	–	﹤0.01%	2322
2024 Q1	$8.63K	Buy	+150	New	+$8.7K	﹤0.01%	2356
2022 Q1	–	Sell	-50	Closed	-$4K	–	3143
2021 Q4	$4K	Buy	+50	New	+$4.28K	﹤0.01%	2464
2020 Q3	–	Sell	-300	Closed	-$22K	–	2610
2020 Q2	$22K	Hold	300	–	–	﹤0.01%	1294
2020 Q1	$14K	Hold	300	–	–	﹤0.01%	1365
2019 Q4	$19K	Hold	300	–	–	﹤0.01%	1285
2019 Q3	$13K	Hold	300	–	–	﹤0.01%	1353
2019 Q2	$16K	Hold	300	–	–	﹤0.01%	1262
2019 Q1	$17K	Hold	300	–	–	﹤0.01%	1231
2018 Q4	$13K	Hold	300	–	–	﹤0.01%	1272
2018 Q3	$21K	Hold	300	–	–	﹤0.01%	1152
2018 Q2	$17K	Hold	300	–	–	﹤0.01%	1211
2018 Q1	$17K	Buy	+300	New	+$18K	﹤0.01%	1082
2015 Q3	–	Sell	-1,588	Closed	-$144K	–	1236
2015 Q2	$144K	Hold	1,588	–	–	0.03%	172
2015 Q1	$126K	Buy	1,588 +220	+16%	+$16.3K	0.03%	175
2014 Q4	$86K	Buy	+1,368	New	+$80.3K	0.02%	222
2014 Q2	–	Sell	-340	Closed	-$14K	–	880
2014 Q1	$14K	Hold	340	–	–	0.01%	364
2013 Q4	$13K	Hold	340	–	–	﹤0.01%	410
2013 Q3	$11K	Buy	+340	New	+$9.85K	﹤0.01%	397

Other funds holding BIB

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

WWM

Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CCWM

Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return

SignatureFD's BIB Position: Q3 2024 in Review

SignatureFD sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2024, closing a stake of 150 shares — an estimated $8.89K sold.

SignatureFD first reported a position in BIB in Q3 2013 and held it in 19 quarters. The position peaked at $144K in Q2 2015. 21 funds tracked by Wall St. Rank hold BIB as of Q3 2024.

SignatureFD reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2024 after selling out during the quarter.
SignatureFD sold 150 ProShares Ultra NASDAQ Biotechnology shares in Q3 2024, an estimated $8.89K.
SignatureFD first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2013 and held it in 19 quarters.
SignatureFD's ProShares Ultra NASDAQ Biotechnology position peaked at $144K in Q2 2015.
21 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2024.

Based on SignatureFD's 13F filing for Q3 2024, filed 21 Oct 2024.